Scheuber P H, Golecki J R, Kickhöfen B, Scheel D, Beck G, Hammer D K
Infect Immun. 1985 Dec;50(3):869-76. doi: 10.1128/iai.50.3.869-876.1985.
The correlation between skin tests and emetic responses in unsensitized monkeys was used to elucidate the cellular site of action of staphylococcal enterotoxin B (SEB). Evidence is presented that SEB administered intradermally provoked immediate-type skin reactions associated with mild degranulation of cutaneous mast cells. The cytoplasma showed signs of synthetic and metabolic activity, with formation of vesicles and increased prominence of mitochondria. Carboxymethylation of histidine residues of SEB altered the molecule (cSEB) from more alkaline components to more acidic species with increased microheterogeneity. This modification caused a loss in toxicity and completely abrogated the skin-sensitizing activity without changing the immunological specificity. cSEB, however, could compete with SEB for binding sites on the target cell surface. Previously, compound 48/80-treated skin sites behaved refractively to challenge with SEB, indicating that mediators from cutaneous mast cells are required for SEB-induced skin reactions. Skin reactions as well as emetic responses challenged with SEB were completely inhibited by H2 receptor antagonists and calcium channel blockers but not by H1 antihistamine or competitive antagonists of serotonin. This new approach provides a model for investigating the mechanisms of SEB action.
利用未致敏猴子皮肤试验与催吐反应之间的相关性来阐明葡萄球菌肠毒素B(SEB)的细胞作用位点。有证据表明,皮内注射SEB会引发速发型皮肤反应,并伴有皮肤肥大细胞的轻度脱颗粒。细胞质显示出合成和代谢活性的迹象,有小泡形成且线粒体更为突出。SEB组氨酸残基的羧甲基化改变了分子(cSEB),使其从碱性更强的成分变为酸性更强的种类,微观异质性增加。这种修饰导致毒性丧失,并完全消除了皮肤致敏活性,同时不改变免疫特异性。然而,cSEB可与SEB竞争靶细胞表面的结合位点。此前,经化合物48/80处理的皮肤部位对SEB激发反应表现出抗性,这表明SEB诱导的皮肤反应需要皮肤肥大细胞释放的介质。H2受体拮抗剂和钙通道阻滞剂可完全抑制SEB激发的皮肤反应和催吐反应,但H1抗组胺药或5-羟色胺竞争性拮抗剂则无此作用。这种新方法为研究SEB作用机制提供了一个模型。